• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从诊断到康复或死亡预测 COVID-19 的进展:将卡斯蒂利亚-莱昂(西班牙)的初级保健和医院记录联系起来。

Predicting COVID-19 progression from diagnosis to recovery or death linking primary care and hospital records in Castilla y León (Spain).

机构信息

Department of Statistics and Operations Research, Universidad de Valladolid, Valladolid, Spain.

MRC-Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.

出版信息

PLoS One. 2021 Sep 20;16(9):e0257613. doi: 10.1371/journal.pone.0257613. eCollection 2021.

DOI:10.1371/journal.pone.0257613
PMID:34543345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8451995/
Abstract

This paper analyses COVID-19 patients' dynamics during the first wave in the region of Castilla y León (Spain) with around 2.4 million inhabitants using multi-state competing risk survival models. From the date registered as the start of the clinical process, it is assumed that a patient can progress through three intermediate states until reaching an absorbing state of recovery or death. Demographic characteristics, epidemiological factors such as the time of infection and previous vaccinations, clinical history, complications during the course of the disease and drug therapy for hospitalised patients are considered as candidate predictors. Regarding risk factors associated with mortality and severity, consistent results with many other studies have been found, such as older age, being male, and chronic diseases. Specifically, the hospitalisation (death) rate for those over 69 is 27.2% (19.8%) versus 5.3% (0.7%) for those under 70, and for males is 14.5%(7%) versus 8.3%(4.6%)for females. Among patients with chronic diseases the highest rates of hospitalisation are 26.1% for diabetes and 26.3% for kidney disease, while the highest death rate is 21.9% for cerebrovascular disease. Moreover, specific predictors for different transitions are given, and estimates of the probability of recovery and death for each patient are provided by the model. Some interesting results obtained are that for patients infected at the end of the period the hazard of transition from hospitalisation to ICU is significatively lower (p < 0.001) and the hazard of transition from hospitalisation to recovery is higher (p < 0.001). For patients previously vaccinated against pneumococcus the hazard of transition to recovery is higher (p < 0.001). Finally, internal validation and calibration of the model are also performed.

摘要

本文使用多状态竞争风险生存模型分析了西班牙卡斯蒂利亚-莱昂地区(约 240 万居民)第一波 COVID-19 患者的动态。从登记为临床过程开始的日期起,假设患者可以通过三个中间状态进展,直到达到恢复或死亡的吸收状态。人口统计学特征、感染时间和先前接种疫苗等流行病学因素、临床病史、疾病过程中的并发症以及住院患者的药物治疗被认为是候选预测因素。关于与死亡率和严重程度相关的危险因素,与许多其他研究一致的结果已经发现,例如年龄较大、男性和慢性疾病。具体而言,69 岁以上患者的住院(死亡)率为 27.2%(19.8%),而 70 岁以下患者的住院(死亡)率为 5.3%(0.7%),男性的住院(死亡)率为 14.5%(7%),而女性的住院(死亡)率为 8.3%(4.6%)。在患有慢性疾病的患者中,住院率最高的是糖尿病,为 26.1%,其次是肾脏疾病,为 26.3%,而脑血管疾病的死亡率最高,为 21.9%。此外,还给出了不同转移的特定预测因子,并通过模型提供了每位患者康复和死亡的概率估计。获得的一些有趣结果是,对于在该时期末感染的患者,从住院到 ICU 的转移风险显著降低(p<0.001),从住院到康复的转移风险更高(p<0.001)。对于先前接种过肺炎球菌疫苗的患者,康复的转移风险更高(p<0.001)。最后,还对模型进行了内部验证和校准。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d6b/8451995/438059aec6ba/pone.0257613.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d6b/8451995/51d17111a0c4/pone.0257613.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d6b/8451995/43f672707936/pone.0257613.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d6b/8451995/0d8dc5888ae0/pone.0257613.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d6b/8451995/2ef47554f015/pone.0257613.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d6b/8451995/438059aec6ba/pone.0257613.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d6b/8451995/51d17111a0c4/pone.0257613.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d6b/8451995/43f672707936/pone.0257613.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d6b/8451995/0d8dc5888ae0/pone.0257613.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d6b/8451995/2ef47554f015/pone.0257613.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d6b/8451995/438059aec6ba/pone.0257613.g005.jpg

相似文献

1
Predicting COVID-19 progression from diagnosis to recovery or death linking primary care and hospital records in Castilla y León (Spain).从诊断到康复或死亡预测 COVID-19 的进展:将卡斯蒂利亚-莱昂(西班牙)的初级保健和医院记录联系起来。
PLoS One. 2021 Sep 20;16(9):e0257613. doi: 10.1371/journal.pone.0257613. eCollection 2021.
2
Temporal trends and forecasting of COVID-19 hospitalisations and deaths in Scotland using a national real-time patient-level data platform: a statistical modelling study.使用国家实时患者层面数据平台对苏格兰新冠肺炎住院和死亡情况的时间趋势及预测:一项统计建模研究
Lancet Digit Health. 2021 Aug;3(8):e517-e525. doi: 10.1016/S2589-7500(21)00105-9. Epub 2021 Jul 5.
3
Development and validation of a prognostic model based on comorbidities to predict COVID-19 severity: a population-based study.基于合并症的 COVID-19 严重程度预测预后模型的建立和验证:一项基于人群的研究。
Int J Epidemiol. 2021 Mar 3;50(1):64-74. doi: 10.1093/ije/dyaa209.
4
[Impact of the COVID-19 epidemic in Friuli Venezia Giulia Region (Northern Italy): assessment of factors associated with the risk of death by competing risks analysis].[新冠疫情对弗留利-威尼斯朱利亚大区(意大利北部)的影响:通过竞争风险分析评估与死亡风险相关的因素]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):128-135. doi: 10.19191/EP20.5-6.S2.111.
5
The first wave of the COVID-19 pandemic in Spain: characterisation of cases and risk factors for severe outcomes, as at 27 April 2020.西班牙 2020 年 4 月 27 日:COVID-19 大流行第一波:病例特征及重症相关危险因素。
Euro Surveill. 2020 Dec;25(50). doi: 10.2807/1560-7917.ES.2020.25.50.2001431.
6
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.
7
Clinical, demographical characteristics and hospitalisation of 3,010 patients with Covid-19 in Friuli Venezia Giulia Region (Northern Italy). A multivariate, population-based, statistical analysis.3010 例新冠病毒肺炎患者在弗留利-威尼斯朱利亚大区(意大利北部)的临床、人口统计学特征和住院情况。一项多变量、基于人群、统计学分析。
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):226-234. doi: 10.19191/EP20.5-6.S2.122.
8
Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.在英格兰,COVID-19 住院后整体和特定病因的住院和死亡:使用 OpenSAFELY 平台中的链接初级保健、二级保健和死亡登记数据进行的队列研究。
PLoS Med. 2022 Jan 25;19(1):e1003871. doi: 10.1371/journal.pmed.1003871. eCollection 2022 Jan.
9
Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.轻症肺炎患者无需住院的情况下使用类固醇进行 COVID-19 门诊治疗作为改变疾病进程的机会:一项随机对照试验的结构化总结。
Trials. 2020 Jul 9;21(1):632. doi: 10.1186/s13063-020-04575-w.
10
Clinical evolution of chronic renal patients with HIV infection in replacement therapy.接受替代治疗的合并人类免疫缺陷病毒感染的慢性肾病患者的临床病程
Nefrologia. 2015;35(5):457-64. doi: 10.1016/j.nefro.2015.06.027. Epub 2015 Sep 26.

引用本文的文献

1
Predicting COVID-19 progression in hospitalized patients in Kurdistan Province using a multi-state model.使用多状态模型预测库尔德斯坦省住院患者的COVID-19病情进展。
J Diabetes Metab Disord. 2025 Mar 22;24(1):88. doi: 10.1007/s40200-025-01576-x. eCollection 2025 Jun.
2
Health trajectories in older patients hospitalized for COVID-19: Results from the GeroCovid multicenter study.老年 COVID-19 住院患者的健康轨迹:GeroCovid 多中心研究结果。
Respir Med. 2023 Jan;206:107088. doi: 10.1016/j.rmed.2022.107088. Epub 2022 Dec 10.
3
Predicting COVID-19 progression in hospitalized patients in Belgium from a multi-state model.

本文引用的文献

1
Risk factors for disease severity in COVID-19 patients: A single-center retrospective study.新型冠状病毒肺炎患者疾病严重程度的危险因素:一项单中心回顾性研究。
J Intensive Med. 2021 Mar 27;1(2):117-122. doi: 10.1016/j.jointm.2021.03.001. eCollection 2021 Oct.
2
The prognostic value of the SOFA score in patients with COVID-19: A retrospective, observational study.SOFA 评分在 COVID-19 患者中的预后价值:一项回顾性、观察性研究。
Medicine (Baltimore). 2021 Aug 13;100(32):e26900. doi: 10.1097/MD.0000000000026900.
3
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK.
基于多状态模型预测比利时住院患者的新冠疫情进展情况。
Front Med (Lausanne). 2022 Nov 23;9:1027674. doi: 10.3389/fmed.2022.1027674. eCollection 2022.
4
Factors Associated with Length of Hospital Stay among COVID-19 Patients in Saudi Arabia: A Retrospective Study during the First Pandemic Wave.沙特阿拉伯新冠肺炎患者住院时间的相关因素:首次疫情高峰期间的一项回顾性研究
Healthcare (Basel). 2022 Jun 27;10(7):1201. doi: 10.3390/healthcare10071201.
5
Diabetes Does Not Increase the Risk of Hospitalization Due to COVID-19 in Patients Aged 50 Years or Older in Primary Care-APHOSDIAB-COVID-19 Multicenter Study.糖尿病不会增加50岁及以上初级保健患者因COVID-19住院的风险——APHOSDIAB-COVID-19多中心研究。
J Clin Med. 2022 Apr 8;11(8):2092. doi: 10.3390/jcm11082092.
COVID-19 第一波疫情期间住院死亡率的变化:使用世卫组织临床特征化方案 UK 的多中心前瞻性观察队列研究。
Lancet Respir Med. 2021 Jul;9(7):773-785. doi: 10.1016/S2213-2600(21)00175-2. Epub 2021 May 14.
4
Hospital load and increased COVID-19 related mortality in Israel.以色列的医院负担与新冠病毒相关死亡率上升
Nat Commun. 2021 Mar 26;12(1):1904. doi: 10.1038/s41467-021-22214-z.
5
Patient factors and temporal trends associated with COVID-19 in-hospital mortality in England: an observational study using administrative data.英格兰 COVID-19 住院患者病死率的相关患者因素和时间趋势:基于行政数据的观察性研究。
Lancet Respir Med. 2021 Apr;9(4):397-406. doi: 10.1016/S2213-2600(20)30579-8. Epub 2021 Feb 15.
6
Development and validation of a machine learning model predicting illness trajectory and hospital utilization of COVID-19 patients: A nationwide study.开发和验证一种机器学习模型,预测 COVID-19 患者的疾病轨迹和医院利用情况:一项全国性研究。
J Am Med Inform Assoc. 2021 Jun 12;28(6):1188-1196. doi: 10.1093/jamia/ocab005.
7
Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE).一项来自意大利北部萨科医院 COVID19 注册研究(SMACORE)的关于 2019 冠状病毒病院内死亡的竞争风险分析
Sci Rep. 2021 Jan 13;11(1):1137. doi: 10.1038/s41598-020-80679-2.
8
Patient Flow Dynamics in Hospital Systems During Times of COVID-19: Cox Proportional Hazard Regression Analysis.新冠疫情期间医院系统中的患者流动动态:Cox 比例风险回归分析。
Front Public Health. 2020 Dec 8;8:585850. doi: 10.3389/fpubh.2020.585850. eCollection 2020.
9
The Clinical Course of Coronavirus Disease 2019 in a US Hospital System: A Multistate Analysis.美国医院系统中 2019 年冠状病毒病的临床病程:一项多州分析。
Am J Epidemiol. 2021 Apr 6;190(4):539-552. doi: 10.1093/aje/kwaa286.
10
COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany.德国动态且不受限制的三级护理模式下 COVID-19 的院内死亡率和死亡方式。
PLoS One. 2020 Nov 12;15(11):e0242127. doi: 10.1371/journal.pone.0242127. eCollection 2020.